|[December 18, 2013]
BIO Commends Senate for Budget Action to Free Up FDA User Fees
WASHINGTON --(Business Wire)--
The Biotechnology Industry Organization (BIO) lauds the Senate for
passing a bipartisan budget deal raising discretionary budget caps,
which should grant the Food and Drug Administration (FDA) complete
access to its user fees for FYs '14 and '15.
The following statement can be attributed to Jim Greenwood, President
and CEO of the Biotechnology Industry Organization (BIO):
"BIO applauds the Senate for its hard work in reaching a bipartisan
budget deal, and again we recognize the House for passing the budget
deal last week.
"Today's Senate decision to release user fees paid by our members to the
FDA will help speed the delivery of breakthrough products and
technologies to the patients who need them most.
"Allowing the FDA full access to these privately paid fees will provide
the agency with the resources it needs to keep pace with scientific
advances while also safeguarding patient safety. Our member companies
bring novel medicines, medical devices and diagnostics to patients, and
need a fully-funded FDA in order to provide patients with the treatments
they need to live longer, healthier lives.
"We look forward to continuing to work with Congress through future
budget processes. Also, we call on the House and the Senate to pass both
S. 1413, the Pryor/Blunt FDA User Fee Protection Act and H.R. 2725, the
Lance/Eshoo FDA SOS (News - Alert) Act, to ensure FDA user fees are permanently
prevented from being sequestered in the future. Holding back FDA user
fees through sequestration puts patients' lives at risk."
For more information on the latest policy issues and legislation
affecting the biotech industry, please visit www.bio.org.
BIO is the world's largest trade association representing biotechnology
companies, academic institutions, state biotechnology centers and
related organizations across the United States and in more than 30 other
nations. BIO members are involved in the research and development of
innovative healthcare, agricultural, industrial and environmental
biotechnology products. BIO also produces the BIO
International Convention, the world's largest gathering of the
biotechnology industry, along with industry-leading investor and
partnering meetings held around the world. BIOtechNOW
is BIO's blog chronicling "innovations transforming our world" and the
BIO Newsletter is the organization's bi-weekly email newsletter." Subscribe
to the BIO Newsletter.
Upcoming BIO Events
CEO & Investor Conference
February 10 - 11, 2014
Asia International Conference
April 8-9, 2014
Congress on Industrial Biotechnology
May 12-15, 2014
June 23-26, 2014
San Diego, CA (News - Alert)
September 16-18, 2014
Sioux Falls, SD
[ Back To Technology News's Homepage ]